These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10241035)

  • 1. Protection of human subjects; Belmont Report: notice of report for public comment.
    Fed Regist; 1979 Apr; 44(76):23191-7. PubMed ID: 10241035
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection of human subjects.
    United States
    Code Fed Regul Shipping; 1982 Oct; Part 46, Sections 46.101 to 46.306():. PubMed ID: 11660819
    [No Abstract]   [Full Text] [Related]  

  • 3. Protection of human subjects; research involving those institutionalized as mentally infirm: report and recommendations of the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research.
    Fed Regist; 1978 Mar; 43(53):11327-58. PubMed ID: 10307340
    [No Abstract]   [Full Text] [Related]  

  • 4. Protection of human subjects; compensating for research injuries; request for comments on report of the President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research.
    Fed Regist; 1982 Nov; 47(226):52880-930. PubMed ID: 10262076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of human subjects of biomedical and behavioral research: notice of report and recommendations for public comments.
    Fed Regist; 1978 May; 44(103):30643-6. PubMed ID: 10241576
    [No Abstract]   [Full Text] [Related]  

  • 6. Protection of human subjects; reports of the President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research--Office of the Assistant Secretary for Health, HHS. Notice of availability of reports.
    Fed Regist; 1983 Jul; 48(146):34408-12. PubMed ID: 10261488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of human subjects: Institutional Review Board; report and recommendations of National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research.
    Fed Regist; 1978 Nov; 43(231):56173-98. PubMed ID: 10239683
    [No Abstract]   [Full Text] [Related]  

  • 8. Position statement of the American Federation for Clinical Research on the DHEW proposed rules on protection of human subjects.
    Levine RJ; Kreisberg RA
    Clin Res; 1975 Feb; 23(2):53-60. PubMed ID: 10297148
    [No Abstract]   [Full Text] [Related]  

  • 9. [Importance of local review committees (institutional review boards) for the protection of experimental subjects].
    Rickels K
    Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1978; 19():94-112. PubMed ID: 714042
    [No Abstract]   [Full Text] [Related]  

  • 10. Informed consent: the FDA's perspective.
    Bagley G
    Food Drug Law J; 1993; 48(2):181-6. PubMed ID: 11653141
    [No Abstract]   [Full Text] [Related]  

  • 11. Protection of human subjects: first biennial report on the adequacy and uniformity of federal rules and policies, and their implementation for the protection of human subjects in biomedical and behavioral research; Report of the President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Department of Health and Human Services. Notice of report for public comment.
    Fed Regist; 1982 Mar; 47(60):13272-305. PubMed ID: 10298467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with boards and commissions concerned with research ethics in the United States.
    McCarthy CR
    Prog Clin Biol Res; 1983; 128():111-22. PubMed ID: 6634724
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA revises informed consent regulations for emergency research.
    Menasché A; Levine RJ
    IRB; 1995; 17(5-6):19-22. PubMed ID: 11653359
    [No Abstract]   [Full Text] [Related]  

  • 14. Protection of human subjects; HEW support of human in vitro fertilization and embryo transfer: report of the Ethics Advisory Board.
    Fed Regist; 1979 Jun; 44(118):35033-58. PubMed ID: 10242488
    [No Abstract]   [Full Text] [Related]  

  • 15. IRBs and pharmaceutical company funding of research.
    Jellinek MS; Levine RJ
    IRB; 1982 Oct; 4(8):9-10. PubMed ID: 11651693
    [No Abstract]   [Full Text] [Related]  

  • 16. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns.
    Kobasic DM
    J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168
    [No Abstract]   [Full Text] [Related]  

  • 17. The war on cancer.
    Hawkins P
    Congr Rec (Dly Ed); 1981 Oct; 127(148):S11610-8. PubMed ID: 11658344
    [No Abstract]   [Full Text] [Related]  

  • 18. The regulation of human experimentation in the United States--a personal odyssey.
    Katz J
    IRB; 1987; 9(1):1-6. PubMed ID: 11649890
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of human subjects in experimentation: informed consent.
    Knepper JD
    J Am Med Rec Assoc (1980); 1982 Dec; 53(6):70-4. PubMed ID: 10257481
    [No Abstract]   [Full Text] [Related]  

  • 20. Ethics of research involving children.
    Lynch A
    Ann R Coll Physicians Surg Can; 1992 Oct; 25(6):371-2. PubMed ID: 11659510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.